Orit Jacobson Selected Research

dimanganese decacarbonyl

12/2018

Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Orit Jacobson Research Topics

Disease

91	Neoplasms (Cancer) 04/2021 - 05/2004
7	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 11/2005
7	Neoplasm Metastasis (Metastasis) 08/2020 - 02/2009
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 08/2020 - 12/2011
3	Inflammation (Inflammations) 08/2020 - 04/2011
3	Insulinoma 01/2019 - 11/2014
3	Glioma (Gliomas) 01/2015 - 04/2011
2	Starvation 05/2019 - 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Disease Progression 12/2020
1	Adenocarcinoma 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Hypoxia (Hypoxemia) 01/2019

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
13	Peptides (Polypeptides)IBA 10/2020 - 11/2010
9	Radioisotopes (Radionuclides)IBA 01/2021 - 07/2004
8	ProdrugsIBA 12/2020 - 11/2005
7	Evans Blue (Blue, Evans)FDA Link 12/2020 - 01/2016
7	AlbuminsIBA 01/2019 - 01/2016
7	GoldIBA 01/2019 - 08/2014
6	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 08/2011
6	IntegrinsIBA 10/2020 - 03/2011
6	Chemokine ReceptorsIBA 02/2016 - 02/2009
5	ErbB Receptors (EGF Receptor)IBA 04/2019 - 05/2004
5	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2017 - 01/2012
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 01/2018
4	Oxygen (Dioxygen)IBA 01/2021 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 03/2019
4	AntigensIBA 12/2020 - 07/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2013
4	PolymersIBA 10/2019 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 04/2019 - 05/2004
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2017
4	AcidsIBA 01/2018 - 05/2004
3	Glutathione (Reduced Glutathione)IBA 04/2021 - 10/2018
3	Metal-Organic FrameworksIBA 10/2020 - 01/2019
3	Glucose OxidaseIBA 01/2020 - 01/2019
3	IonsIBA 10/2019 - 01/2018
3	177Lu-EB-PSMA-617IBA 06/2019 - 01/2018
3	GadoliniumIBA 03/2019 - 09/2017
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 11/2014
3	Exenatide (Byetta)FDA Link 01/2019 - 11/2014
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2015
3	Chelating AgentsIBA 01/2018 - 12/2011
2	RadiopharmaceuticalsIBA 10/2020 - 01/2018
2	Biological ProductsIBA 08/2020 - 01/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 01/2016
2	PorphyrinsIBA 01/2020 - 01/2019
2	IronIBA 01/2020 - 03/2019
2	EnzymesIBA 01/2020 - 05/2019
2	PolyphenolsIBA 10/2019 - 03/2019
2	177Lu-PSMA-617IBA 06/2019 - 01/2019
2	PeryleneIBA 01/2019 - 01/2017
2	SolutionsIBA 01/2019 - 01/2017
2	polyoxometalateIBA 12/2018 - 10/2018
2	Ferritins (Ferritin)IBA 01/2018 - 03/2016
2	CopperIBA 01/2018 - 03/2016
2	Copper-64IBA 01/2018 - 01/2011
2	cupric sulfide (CuS)IBA 01/2018 - 03/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2015 - 04/2015
2	Sulfhydryl Compounds (Thiols)IBA 10/2015 - 11/2014
2	cyclic arginine-glycine-aspartic acid peptideIBA 12/2011 - 03/2011
2	CationsIBA 08/2011 - 04/2011
2	LigandsIBA 04/2011 - 11/2010
2	AndrogensIBA 08/2006 - 11/2005
2	Androgen Receptors (Androgen Receptor)IBA 08/2006 - 11/2005
1	DisulfidesIBA 04/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 04/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2021
1	Peptide Receptors (Peptide Receptor)IBA 01/2021
1	somatostatin receptor 2IBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 08/2020
1	zileuton (Zyflo)FDA Link 08/2020
1	68Ga- 1,4,7- triazacyclononane- N,N',N''- triacetic acidIBA 01/2020
1	ZirconiumIBA 01/2020
1	68Ga-NOTA-RM26IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 10/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Tirapazamine (SR 4233)IBA 01/2019
1	Photosensitizing Agents (Photosensitizers)IBA 01/2019
1	BilirubinIBA 01/2019
1	iron pentacarbonylIBA 01/2019
1	Contrast MediaIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	dimanganese decacarbonylIBA 12/2018
1	lutetium Lu 177 dotatateIBA 11/2018
1	MetalsIBA 01/2018

Therapy/Procedure

47	Therapeutics 04/2021 - 01/2007
19	Precision Medicine 08/2020 - 01/2013
10	Radiotherapy 01/2021 - 01/2007
9	Photothermal Therapy 05/2019 - 08/2014
8	Photochemotherapy (Photodynamic Therapy) 01/2021 - 01/2016
7	Drug Therapy (Chemotherapy) 01/2019 - 01/2011
4	Intravenous Injections 10/2019 - 09/2015
4	Lasers (Laser) 01/2019 - 09/2015
3	Castration 12/2020 - 01/2019
3	Immunotherapy 01/2019 - 11/2017
3	Aftercare (After-Treatment) 01/2018 - 08/2006
1	Chemoradiotherapy 01/2019